Cargando…

Changes in drug disposition of lithium during pregnancy: a retrospective observational study of patient data from two routine therapeutic drug monitoring services in Norway

OBJECTIVES: Pregnancy may cause changes in drug disposition, dose requirements and clinical response. For lithium, changes in disposition during pregnancy have so far been explored in a single-dose study on 4 participants only. The aim of this study was to determine the effect of pregnancy on serum...

Descripción completa

Detalles Bibliográficos
Autores principales:	Westin, Andreas Austgulen, Brekke, Malin, Molden, Espen, Skogvoll, Eirik, Aadal, Marianne, Spigset, Olav
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2017
Materias:	Pharmacology and Therapeutics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5353288/ https://www.ncbi.nlm.nih.gov/pubmed/28249852 http://dx.doi.org/10.1136/bmjopen-2016-015738

Ejemplares similares

Selective serotonin reuptake inhibitors and venlafaxine in pregnancy: Changes in drug disposition
por: Westin, Andreas Austgulen, et al.
Publicado: (2017)

Correction: Selective serotonin reuptake inhibitors and venlafaxine in pregnancy: Changes in drug disposition
por: Westin, Andreas Austgulen, et al.
Publicado: (2018)

Treatment With Antipsychotics in Pregnancy: Changes in Drug Disposition
por: Westin, Andreas A., et al.
Publicado: (2017)

Discrepancies in drug histories at admission to gastrointestinal surgery, internal medicine and geriatric hospital wards in Central Norway: a cross-sectional study
por: Sund, Janne Kutschera, et al.
Publicado: (2017)

Co-prescription of metoprolol and CYP2D6-inhibiting antidepressants before and after implementation of an optimized drug interaction database in Norway
por: Gedde-Dahl, Ane, et al.
Publicado: (2022)

Effect of Proton Pump Inhibitors on the Serum Concentrations of the Selective Serotonin Reuptake Inhibitors Citalopram, Escitalopram, and Sertraline
por: Gjestad, Caroline, et al.
Publicado: (2015)

Meta-analysis: the effects of smoking on the disposition of two commonly used antipsychotic agents, olanzapine and clozapine
por: Tsuda, Yoshiyuki, et al.
Publicado: (2014)

CYP2D6 Reduced Function Variants and Genotype/Phenotype Translations of CYP2D6 Intermediate Metabolizers: Implications for Personalized Drug Dosing in Psychiatry
por: Molden, Espen, et al.
Publicado: (2021)

A prospective study of adverse drug reactions to antiepileptic drugs in children
por: Anderson, Mark, et al.
Publicado: (2015)

Predicting the risk of drug–drug interactions in psychiatric hospitals: a retrospective longitudinal pharmacovigilance study
por: Wolff, Jan, et al.
Publicado: (2021)

Differences in drug utilisation between men and women: a cross-sectional analysis of all dispensed drugs in Sweden
por: Loikas, Desirée, et al.
Publicado: (2013)

Drug exposure during pregnancy in primary care: an algorithm and observational study from SIDIAP database, Catalunya, Spain
por: Lestón Vázquez, Marta, et al.
Publicado: (2023)

Metformin serum concentrations during pregnancy and post partum – A clinical study in patients with polycystic ovary syndrome
por: Espnes, Ketil Arne, et al.
Publicado: (2022)

Multiple treatment comparison of seven new drugs for patients with advanced malignant melanoma: a systematic review and health economic decision model in a Norwegian setting
por: Pike, Eva, et al.
Publicado: (2017)

Pregnancy outcomes following maternal exposure to second-generation antipsychotics given with other psychotropic drugs: a cohort study
por: Sadowski, Alexander, et al.
Publicado: (2013)

Surveillance of adverse drug reactions at an adverse drug reaction monitoring centre in Central India: a 7-year surveillance study
por: Sharma, Megha, et al.
Publicado: (2021)

Drug-Associated Risk Tool: development and validation of a self-assessment questionnaire to screen for hospitalised patients at risk for drug-related problems
por: Kaufmann, Carole P, et al.
Publicado: (2018)

How innovative are new drugs launched in the UK? A retrospective study of new drugs listed in the British National Formulary (BNF) 2001–2012
por: Ward, Derek J, et al.
Publicado: (2014)

β-Blocker treatment during pregnancy and adverse pregnancy outcomes: a nationwide population-based cohort study
por: Meidahl Petersen, Kasper, et al.
Publicado: (2012)

Lithium for Fracture Treatment (LiFT): a double-blind randomised control trial protocol
por: Nam, Diane, et al.
Publicado: (2020)

Antidopaminergic drugs and acute pancreatitis: a population-based study
por: Bodén, Robert, et al.
Publicado: (2012)

Assessment of drug use pattern using WHO core drug use indicators in selected general hospitals: a cross-sectional study in Tigray region, Ethiopia
por: Tassew, Segen Gebremeskel, et al.
Publicado: (2021)

Drug–drug interaction between dexamethasone and direct-acting oral anticoagulants: a nested case–control study in the National COVID Cohort Collaborative (N3C)
por: Kravchenko, Olga V, et al.
Publicado: (2022)

Clarity and applicability of adverse drug reaction-related monitoring instructions in clinical practice guidelines for children and adolescents treated with antipsychotic drugs: a review of six clinical practice guidelines
por: Minjon, Lenneke, et al.
Publicado: (2022)

Determination of risk factors for drug-related problems: a multidisciplinary triangulation process
por: Kaufmann, Carole P, et al.
Publicado: (2015)

Global prevalence of antidepressant drug utilization in the community: protocol for a systematic review
por: Lunghi, Carlotta, et al.
Publicado: (2022)

Comparing two types of macrolide antibiotics for the purpose of assessing population-based drug interactions
por: Fleet, Jamie L, et al.
Publicado: (2013)

Off-label drug prescriptions in French general practice: a cross-sectional study
por: Drogou, François, et al.
Publicado: (2019)

A question–answer pair (QAP) database integrated with websites to answer complex questions submitted to the Regional Medicines Information and Pharmacovigilance Centres in Norway (RELIS): a descriptive study
por: Schjøtt, Jan, et al.
Publicado: (2012)

How are drug regimen changes during hospitalisation handled after discharge: a cohort study
por: Viktil, Kirsten K, et al.
Publicado: (2012)

Health Canada's use of its priority review process for new drugs: a cohort study
por: Lexchin, Joel
Publicado: (2015)

Adverse drug reactions, multimorbidity and polypharmacy: a prospective analysis of 1 month of medical admissions
por: Osanlou, Rostam, et al.
Publicado: (2022)

Behaviour change interventions to promote prescribing of generic drugs: a rapid evidence synthesis and systematic review
por: Moe-Byrne, Thirimon, et al.
Publicado: (2014)

Trends in clinical development timeframes for antiviral drugs launched in the UK, 1981–2014: a retrospective observational study
por: Ward, Derek J, et al.
Publicado: (2015)

Healthcare professionals knowledge, attitude and practice of adverse drug reactions reporting in Ethiopia: a cross-sectional study
por: Gidey, Kidu, et al.
Publicado: (2020)

Evaluation of exposure to effervescent drugs in a large health check-up population in France: a cross-sectional study
por: Perrin, Germain, et al.
Publicado: (2018)

Postmarketing studies for novel drugs approved by both the FDA and EMA between 2005 and 2010: a cross-sectional study
por: Zeitoun, Jean-David, et al.
Publicado: (2017)

Trends of prescribing antimicrobial drugs for urinary tract infections in primary care in the Netherlands: a population-based cohort study
por: Mulder, Marlies, et al.
Publicado: (2019)

Clinical and economic impact of adverse drug reactions in hospitalised patients: prospective matched nested case–control study in Ethiopia
por: Sendekie, Ashenafi Kibret, et al.
Publicado: (2023)

Process of drug registration in Israel: the correlation between the number of discussions within the Ministry of Health and postapproval variations by EMA and/or FDA
por: Hiayev, Stephany, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jghro0otnkhc5j0giaq2c2euqj